(Q41478121)

1 October 2017

An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis (English)

1 reference

1 October 2017

0 references

1 reference

Huizinga TW

1

1 reference

1 October 2017

Dijkmans BA

2

1 reference

1 October 2017

van der Velde EA

3

1 reference

1 October 2017

van de Pouw Kraan TC

4

1 reference

1 October 2017

Verweij CL

5

1 reference

1 October 2017

Breedveld FC

6

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Annals of the Rheumatic Diseases

1 October 2017

1 reference

1 October 2017

55

1 reference

1 October 2017

11

1 reference

1 October 2017

833-836

1 reference

Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

Thalidomide as salvage therapy for chronic graft-versus-host disease

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010320

19 August 2018

No need for a dry run

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8976641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8976641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8976641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.55.11.833

1 reference

1 October 2017

1 reference

1 October 2017

PubMed publication ID

8976641

1 reference